Coronavirus
📧 Sign up to get email alerts when something new happens for Coronavirus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: COVID-19 Convalescent Plasma [EARLY_Phase 1]
EARLY_PHASE1 trial of COVID-19 convalescent plasma completed; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: Medical Masks vs N95 Respirators for COVID-19 [Phase 4]
Phase 4 clinical trial comparing medical masks to N95 respirators for COVID-19 completed.
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: Lianhua Qingke for the Rehabilitation of Patient With Omicron Infection [Phase 4]
A Phase 4 clinical trial update for Lianhua Qingke in rehabilitation of patients with Omicron infection is listed, with unclear status.
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2) [Phase 3]
Phase 3 trial update for fluvoxamine in early treatment of Covid-19 (Stop Covid 2) has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19 [Phase 2]
Phase 2 study evaluating axatilimab for hospitalized COVID-19 patients with respiratory involvement was terminated; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Convalescent Plasma to Stem Coronavirus (CSSC-001) [Phase 2]
Phase 2 trial update on convalescent plasma for coronavirus treatment completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers [Phase 1]
Phase 1 study assessing safety, tolerability, and pharmacokinetics of EIDD-2801 in healthy volunteers has been completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) [Phase 3]
Phase 3 randomized trial comparing high-dose versus standard-dose Vitamin D3 in high-risk COVID-19 patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-03Clinical Trial Update: Clinical Study of Recombinant Novel Coronavirus Vaccine [Phase 2]
Phase 2 clinical study update for a recombinant novel coronavirus vaccine.
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: A Study of a Candidate COVID-19 Vaccine (COV003) [Phase 3]
Clinical trial update for a candidate COVID-19 vaccine (COV003) in Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection [Phase 1, Phase 2]
Clinical trial update for the COVID-19 vaccine ChAdOx1 nCoV-19 in South African adults with and without HIV (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Convalescent Plasma for Patients With COVID-19: A Pilot Study [Phase 2]
A Phase 2 pilot study evaluating convalescent plasma in patients with COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Tocilizumab in Coronavirus-19 Positive Patients [Phase 3]
Phase 3 clinical trial update for tocilizumab in COVID-19 patients; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: The Respiratory Protection Effectiveness Clinical Trial [NA]
A completed clinical trial update from Johns Hopkins on respiratory protection effectiveness; results posted in 2019.